Riskpilot← Back to searchSign inGet full accessLYNGEN KLINIKKEN AS
ASActiveOrg 918474102Parkveien 15, 9060 LyngseidetPhysiotherapy activities · NACE 8695Est. 20171 employees
Revenue 2024
NOK 1,9M
+17% vs 2023
EBITDA margin
3.8%
-70% vs 2023
Equity ratio
69.7%
Financial strength
Net profit 2024
NOK 9K
-93% vs 2023
| Revenue | NOK 1,9M | +17% |
| EBITDA | NOK 72K | -70% |
| Net profit | NOK 9K | -93% |
| Total assets | NOK 601K | -5% |
| Equity | NOK 419K | +2% |
| Employees | 1 | — |
Legal name
LYNGEN KLINIKKEN AS
Org number
918474102
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
30. januar 2017
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hege therese robertsen
Company purpose
Manuellterapi, fysioterapi, akupunktur og andre produkter/tjenester som naturlig hører sammen med dette, herunder å delta i andre selskap med lignende virksomhet, og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak.
Address
Parkveien 15, 9060 Lyngseidet
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 947 | 1 124 | 1 090 | 1 614 | 1 893 |
| Staff expenses | −477 | −628 | −539 | −719 | −857 |
| EBITDA | 148 | 125 | 115 | 240 | 72 |
| Depreciation & amort. | −12 | −39 | −67 | −58 | −58 |
| EBIT | 136 | 85 | 48 | 182 | 15 |
| Net financials | −0 | −27 | −0 | −0 | −1 |
| Profit before tax | 136 | 58 | 48 | 182 | 13 |
| Tax | 30 | −17 | 13 | 40 | 4 |
| Net profit | 106 | 75 | 35 | 142 | 9 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 306 | 379 | 417 | 633 | 601 |
| Equity | 158 | 233 | 267 | 410 | 419 |
| Long-term debt | 0 | 2 | 0 | 38 | 28 |
| Short-term debt | 148 | 144 | 149 | 185 | 154 |
| Total debt | 148 | 147 | 149 | 223 | 182 |
EBITDA margin
3.8%
This company
15.8%
Market median
-76% vs market
20202024
Equity ratio
69.7%
This company
38.2%
Market median
+82% vs market
20202024
Return on equity
2.2%
This company
18.4%
Market median
-88% vs market
20202024
Net profit margin
0.5%
This company
8.1%
Market median
-94% vs market
20202024
Asset turnover
3.15×
This company
1.12×
Market median
+181% vs market
20202024
Debt / equity
0.43×
This company
0.62×
Market median
+31% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HT Chief Executive Officer | Chief Executive Officer | 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LYNGEN KLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hege Therese Robertsen | Chief Executive Officer | 0 companies |
| Kjetil Ribe | Board of Directors | 0 companies |